Abbott Molecular, Inc.: FDA filings under this applicant name

FDA lists 18 510(k) clearances under 2 spellings of the applicant name “Abbott Molecular, Inc.” (first 2008, latest 2025), plus 14 PMA and 1 De Novo decisions, across 25 product codes in 4 review panels. Median 510(k) review time under this name: 246 days. Since 2017 the median was 235 days, against 171 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

Caduvo groups this applicant name under Abbott, based on public ownership records.

510(k) clearances per year

YearClearancesMedian review days
20120—
20131112
2014186
20150—
20160—
20170—
20180—
20190—
20200—
20210—
20222446
20231210
20242202
20256246
20260—

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Abbott Molecular, Inc. took a median 235 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 171 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
MZPAssay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus31
PABCytomegalovirus (Cmv) Dna Quantitative Assay31
MKTHepatitis Viral B Dna Detection20
OWDSomatic Gene Mutation Detection System20
QEPNucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections22
QLXNucleic Acid Amplification Test For The Quantitation Of Epstein-Barr Virus (Ebv) Dna22
LSKDna-Reagents, Chlamydia11
LSLDna-Reagents, Neisseria11
MAQKit, Dna Detection, Human Papillomavirus10
MKZDna Probe, Nucleic Acid Amplification, Chlamydia11

Plus 15 more product codes.

Review panels

Most recent Abbott Molecular, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K252102Alinity m HCVMZP2025-09-2584
K243489Alinity m EBV (09N43-095)QLX2025-07-28258
K243485Alinity m CMVPAB2025-07-01235
K241921Alinity m BKVQMI2025-03-24266
K241573Alinity m Resp-4-PlexQOF2025-02-14256
K243410simpli-COLLECT STI TestQYA2025-01-3090
K241580Alinity m SARS-CoV-2 AMP Kit (09N78-096); Alinity m SARS-CoV-2 CTRL Kit (09N78-086)QQX2024-12-06186
K233349Alinity m HSV 1 & 2 / VZVPGI2024-05-03217
K222379Alinity m STI AssayQEP2023-03-03210
K212778Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075)QLX2022-07-15317

8 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P230003PMAAlinity m HR HPV2023-11-01
P210022PMAAlinity m CMV2022-05-05
P200013PMAAlinity m HBV2020-08-29
P190025PMAAlinity m HCV2020-03-23
P170041PMAAbbott RealTime IDH12018-07-20

Recalls

47 product recalls in 34 recall events; 24 initiated in the last five years. Most recent: 2025-04-28.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Parent company SEC filings

ABBOTT LABORATORIES (ABT): EDGAR filings, CIK 1800. Caduvo groups Abbott Molecular, Inc. under Abbott; the parent's SEC registrant is entered by hand for the group, not matched by name.

FDA spellings included

FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Abbott Molecular, Inc.?

FDA lists 18 510(k) clearances under 2 spellings of the applicant name “Abbott Molecular, Inc.” (first 2008, latest 2025), plus 14 PMA and 1 De Novo decisions, across 25 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Abbott Molecular, Inc.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Abbott Molecular, Inc. is 246 days. Since 2017: 235 days, versus 171 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Abbott Molecular, Inc.?

The most frequent FDA product codes under this applicant name are MZP (Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus, 3); PAB (Cytomegalovirus (Cmv) Dna Quantitative Assay, 3); MKT (Hepatitis Viral B Dna Detection, 2).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup